Sangamo Therapeutics Inc (SGMO)
1.22
-0.15
(-10.95%)
USD |
NASDAQ |
Jan 08, 11:02
Sangamo Therapeutics Profit Margin (Quarterly): 21.60% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 25.22% |
| Verastem Inc | -- |
| AIM ImmunoTech Inc | -10.57K% |
| Protalix BioTherapeutics Inc | 18.02% |
| Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -199.9% |
| Return on Assets | -93.87% |
| Return on Invested Capital | -199.9% |
| Operating Margin (Quarterly) | 21.52% |
| Return on Net Operating Assets | -278.0% |